Hey Klementina Österberg ...

... CEO at GU Holding, which awards SEK 120, 000 to three female entrepreneurs.

BMAs: Run your own business

After graduation you must decide: be an employee or start your own business. This is not really the situation for BMAs today, but a collaborative project between Swedish public actors and some companies aims to change that and make entrepreneurs of BMAs.

A crash course in IP strategy

"Publish, publish, publish!" Sound familiar? So to meet the researcher's wishes, do you scribble a patent application with lipstick on a napkin and send it in? At the seminar Patent Strategies in the Biotech Company, you will have the chance to find out why this might not be the best idea.

From planning stage to handshake

"Partnering is an effective tool to get in touch with the decision makers high up in an organization's administration," says Camilla Huse Bondeson at Conlega. And according to her, rigorous planning is the way to succeed.

Young, bright and committed to labtech

Ghazal Voghoui recently bought her first apartment and finally settled in Stockholm again. Last year, she finished her law studies and she is relieved to be back after living in Geneva for four years. On November 10 she will take a big career leap, becoming the new CEO of Swedish Labtech.

Diagnostics to deal with new diseases

Maria Brytting at the Swedish Institute for Infectious Disease Control, SMI, will share her experiences from April 2009 when the new influenza A virus, H1N1, was first reported globally.

Studie av fetmamedicin på paus

Ett läkemedel som Novo Nordisk tagit fram för behandling av diabetes typ II fungerar även som bantingsmedel. Det visar en fas II studie av preparatet. Men Novo Nordisk har lagt fortsatta studier på is.

Se upp för konsulten!

Kliniska prövningar blir allt dyrare i Sverige och många företag vänder sig utomlands för att gör sina studier. Men företagen måste vara klara över vad de behöver hjälp med och se igenom CRO-företagens säljarfloskler, annars riskerar outsouringaffären att bli allt annat än lyckad.

Gel i rumstemperatur - vätska i kylrummet

Biostatus presenterar en fixeringsgel för användning vid fotografering som blir vätska i kylskåpstemperatur och gel i rumstemperatur.

MS minskar cancerrisken

Personer med multipel skleros löper högre risk än andra att drabbas av vissa cancerformer. Den generella risken för cancer är dock lägre än för andra, något som troligtvis beror på förändringar i patienternas livsstil.

Han är flitigast i världen

Världens mest produktive Alzheimersforskare finns på Karolinska Institutet. En internationell bibliometrisk studie rankar honom högst bland 135 000 kollegor.

New member to Active board

The Election Committee of Active Biotech proposes a very experienced financial sector executive to join the company board. Five existing members are also to be re-elected at the AGM in May.

EUR 2 million for peanut allergies

ALK Abelló has signed an agreement to invest EUR 2 million in the French biotechnology company DBV Technologies.

EU says yes to Roche drug

EU approves a first in class therapy for treatment of patients with moderate to severe form of rheumatoid arthritis.

Oasmia gets a confirmation

FDA has granted Oasmia an expedited review status for Paclical Vet.

New NO product reduces diabetic pain

The Swedish medtech company Nolabs has announced that it has achieved an important milestone in the development of a new line of products.

Positive combined cancer therapy

Topotarget announces positive data with new treatment against colorectal cancer.

Woman deficit in Swedish research

The IP firm Awapatent will soon launch its Innovation Barometer 2009. This year Awapatent reveals that the statistics is even worse, compared to last year.

Measure blood sugar without finger pricking

The Danish entrepreneurial firm RSP Systems has developed a method to measure the blood sugar level in diabetes patients, simply by placing a fingertip on a small illuminating lens.

Medicult disclaims Swedish offer

The Norwegian company Medicult's Board is highly sceptical to the yesterday announced Vitrolife offer.

LEO Pharma - International Clinical Trial Manager

Prenatal testing breakthrough

For the first time specific gene expression information from fetal cells isolated from maternal blood samples is available.

Danish discovery could help cardiac patients

The Danish researchers have developed a component that could make live easier forpatients with heart failure.

Cancer cells cheat suicide call

Cancer cells cheat death by reversing a process which causes normal cells to commit suicide at the end of their natural life, researchers from the University of Hong Kong have shown.